Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma

An early decrease in ctDNA concentration is a strong predictor of the therapeutic efficacy of ICI plus chemotherapy in advanced gastric/GEJ adenocarcinoma. Clinical Trial Information NCT03959293 (DURIGAST).

Authors

Institutions

Publication Details

Journal
Communications Medicine
Published
2025-04-24
DOI
https://doi.org/10.1038/s43856-025-00867-x
Citations
6
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
5.62

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma

Laure Kaluzinski, Benoist Chibaudel, Caroline Pétorin, Nicolas Etchepare et al.
6 citations
Communications Medicine
Cancer Genomics and Diagnostics
5.62
article

Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma

Laure Kaluzinski, Benoist Chibaudel, Caroline Pétorin, Nicolas Etchepare, Karine Le Malicot, Côme Lepage, Aziz Zaanan, Valérie Taly, David Tougeron, Thomas Aparicio, Ludovic Evesque, Antoine Angelergues, Gilles Breysacher, Aurélien Carnot, Anaïs Bodère, Jean‐François Emile, Jérôme Desrame, Hanane Djamai, May Mabro, Yves Rinaldi, Pierre Laurent‐Puig, Aurélia Baures, C. Louvet
article en
6 citations

Abstract

An early decrease in ctDNA concentration is a strong predictor of the therapeutic efficacy of ICI plus chemotherapy in advanced gastric/GEJ adenocarcinoma. Clinical Trial Information NCT03959293 (DURIGAST).

Communications MedicineVol. 5(1)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Université de Bourgogne (FR), Université Paris Cité (FR), Université de Lille (FR), Université Paris-Saclay (FR), Université de Poitiers (FR), Sorbonne Université (FR), Sorbonne Paris Cité (FR), Institute Mutualiste Montsouris (FR), Centre de Recherche des Cordeliers (FR), Hopitaux Civils de Colmar (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Européen Georges-Pompidou (FR), The Enteric Nervous System in Gut and Brain Disorders (FR), Hôpital Européen (FR), Immunité et Cancer (FR), Centre Hospitalier Universitaire de Poitiers (FR), Groupe Hospitalier Diaconesses Croix Saint-Simon (FR), Centre Hospitalier de Saint-Malo (FR), Fédération Francophone de Cancérologie Digestive (FR), Hôpital Privé Jean Mermo (FR), Centre Hospitalier Universitaire de Clermont-Ferrand (FR), Centre Oscar Lambret (FR), Hôpital Ambroise-Paré (FR), Centre Hospitalier de Valence (FR), Institut Hospitalier Franco Britannique (FR), Centre de recherche Translationnelle en Médecine moléculaire (FR), Hôpital Saint-Louis (FR), Centre Hospitalier Public du Cotentin (FR), Centre Antoine Lacassagne (FR), Hôpital Foch (FR)
AstraZeneca, Unicancer
Good health and well-being
Openalex Percentile: Top 4%
Cancer Genomics and Diagnostics
5.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.